Introduction
============

The morbidity and mortality of atherosclerotic coronary heart disease (CHD) have increased with the development of economy and the improvement of human living standard, and heart disease is ranked first of the diseases seriously threatening human life and health at present ([@b1-etm-0-0-7111]). Studies have shown that male incidence is higher than female, it is not completely clear what the specific pathogenesis of CHD is, and there are various theories, including endothelial dysfunction, inflammatory reaction and lipid deposition hypothesis ([@b2-etm-0-0-7111],[@b3-etm-0-0-7111]). In addition to sex, age and blood lipid, the pathogenic factors affecting CHD are mainly related to blood sugar, blood pressure, obesity, smoking, and drinking. In recent years, a large number of studies have proved that homocysteine (Hcy) is also one of the risk factors for CHD ([@b4-etm-0-0-7111]--[@b6-etm-0-0-7111]).

Hcy, a non-essential amino acid, is converted mainly from methionine intake in the diet ([@b7-etm-0-0-7111]). It has been reported that Hcy may damage vascular endothelial cells and affect lipid metabolism, contributing to the occurrence of atherosclerosis, thus inducing cardiovascular and cerebrovascular diseases, but it is not completely clear what the mechanism is ([@b8-etm-0-0-7111],[@b9-etm-0-0-7111]). Abnormal lipid metabolism is the most important risk factor in atherosclerosis. Generally speaking, indicators of blood lipid include total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) ([@b10-etm-0-0-7111]). Studies have found that Hcy participates in and speeds up the auto-oxidation of LDL, while oxidized LDL cannot be recognized by normal LDL receptors, leading to the occurrence and development of acute coronary syndrome ([@b11-etm-0-0-7111]).

The purpose of this study is to compare the Hcy and blood lipid level in serum of CHD patients with that of healthy people and to perform statistical analysis on the risk factors for CHD, to provide reference value for the assessment of disease and the prevention and prognosis of CHD.

Patients and methods
====================

### General information

A total of 148 patients who were diagnosed as CHD patients by coronary arteriography in Weifang People\'s Hospital (Weifang, China) between January 2014 and December 2017 were collected as study group using retrospective methods, including 89 male and 59 female with an average age of 56.42±9.84 years. The study group was divided into 67 cases in angina pectoris group, 49 cases in acute myocardial infarction group and 32 cases in old myocardial infarction group according to the clinical characteristics. Another 120 healthy people in the same period were selected as control group, including 64 males and 56 females with an average age of 54.21±12.0 years. Exclusion criteria were: Subjects who were pregnant, with lactation, tumors, liver and renal insufficiency and various infections and immune diseases. No drugs affecting Hcy metabolism were used and no steroid drug therapy was received by the patients within the 2 months of the study. A total of 268 subjects signed the informed consent. General information on the candidates is shown in [Table I](#tI-etm-0-0-7111){ref-type="table"}. The study was approved by the Ethics Committee of Weifang People\'s Hospital.

### Instruments and reagents

The DNM-9606 enzyme marker analyzer was purchased from Beijing Plang New Technology Co., Ltd. (Beijing, China); Hcy ELISA kit from Xiamen Huijia Biotechnology Co., Ltd. (Xiamen, China); HI7100 biochemistry analyzer and its reagents from Hitachi, Ltd. (Tokyo, Japan); blood lipid kit from Shanghai Yubo Biotechnology Co., Ltd. (Shanghai, China).

### Determination of Hcy and blood lipid levels in serum

All subjects were fasting for \>12 h on an empty stomach before examination and no smoking, drinking and high-fat food for 24 h. Venous blood (3 ml) was collected from patients on an empty stomach in the study and control group, and Hcy and blood lipid content in serum were determined using centrifugation at 8,000 × g for 20 min at 4°C. The Hcy level in serum was determined quantitatively using enzyme-linked immunosorbent assay. TC was determined using enzyme method, TG using glycerol phosphate oxidase method and HDL-C and LDL-C using selective inhibition method. The indicator of each group was determined 3 times and its average value was taken. All steps were strictly in accordance with the instructions.

### Statistical analysis

Data analysis was performed using SPSS 17.0 statistical software (SPSS, Inc., Chicago, IL, USA). The enumeration data were tested by χ2 test, the comparison of measurement data between groups was tested by t-test, the comparison among multiple groups was performed using one-way ANOVA, and pairwise comparison between groups was performed using SNK-q test. Analysis of risk factors for the disease was performed using logistic regression. At P\<0.05, the difference was considered statistically significant.

Results
=======

### Comparison of Hcy and blood lipid levels in serum between the two groups

Comparison of Hcy and blood lipid levels in serum between the study and control group was performed. The HDL-C level in the study group was significantly lower than that in control group, while the levels of Hcy, TC, TG and LDL-C were significantly higher than that in control group, and the differences were statistically significant (P\<0.001). Specific information is shown in [Fig. 1](#f1-etm-0-0-7111){ref-type="fig"} and [Table II](#tII-etm-0-0-7111){ref-type="table"}.

### Comparison of Hcy and blood lipid levels in serum in different types of CHD

The study group was divided into angina pectoris, acute myocardial infarction and old myocardial infarction group according to the clinical manifestations of CHD patients. The difference was not statistically significant in the HDL-C level in patients among the three groups (P\>0.05), but the differences were statistically significant in the levels of Hcy, TC, TG and LDL-C in serum of patients among the three groups (P\<0.05). The Hcy level in acute and old myocardial infarction group was higher than that in angina pectoris group, and in old myocardial infarction group was lower than in acute myocardial infarction group (P\<0.05); the TC level in angina pectoris group was higher than that in acute and old myocardial infarction group, and in acute myocardial infarction group was higher than in old myocardial infarction group (P\<0.05); the TG level in acute and old myocardial infarction group was lower than that in angina pectoris group, and in old myocardial infarction group was lower than in acute myocardial infarction group (P\<0.05); the LDL-C level in acute and old myocardial infarction group was lower than that in angina pectoris group, and in old myocardial infarction group was lower than in acute myocardial infarction group (P\<0.05). Specific information is shown in [Fig. 2](#f2-etm-0-0-7111){ref-type="fig"} and [Table III](#tIII-etm-0-0-7111){ref-type="table"}.

### Analysis of risk factors for CHD

BMI\>25 was considered as obesity, and logistic regression analysis was performed on the factors with statistically significant difference used as independent variables. The results of univariate analysis showed that CHD was associated with Hcy, hyperlipidemia, smoking, hypertension and diabetes (P\<0.05), but had no relationship with drinking and obesity (P\>0.05). The results of multivariate analysis showed that Hcy, hyperlipidemia, hypertension and diabetes were independent risk factors for CHD, and the difference was statistically significant (P\<0.05). Specific information is shown in [Tables IV](#tIV-etm-0-0-7111){ref-type="table"} and [V](#tV-etm-0-0-7111){ref-type="table"}.

Discussion
==========

CHD is more common and even fatal in middle-aged and elderly people, the main pathological manifestation of which is cardiac insufficiency. Cardiac insufficiency is due to the coronary atherosclerotic plaque causing stenosis and blockage of arteries, thus inducing other clinical manifestations ([@b12-etm-0-0-7111]). A large number of previous reports have shown that the cholesterol level is associated with heart disease. However, in recent years, studies have shown that Hcy is an independent risk factor for CHD ([@b13-etm-0-0-7111],[@b14-etm-0-0-7111]). The specific reason is not clear why Hcy and blood lipid levels in serum are associated with CHD risk, but it has proved that CHD risk increases with the increase of Hcy and blood lipid levels in serum ([@b15-etm-0-0-7111]).

This study compared Hcy and blood lipid levels in serum between the study and control group. The HDL-C level in the study group was significantly lower than that in control group, while the levels of Hcy, TC, TG and LDL-C were significantly higher than that in control group, and the differences were statistically significant (P\<0.001). The study of Granberry *et al* ([@b16-etm-0-0-7111]) was consistent with our results that HDL-C had the effect of preventing atherosclerosis. Generally, the decrease of HDL-C level in CHD patients may be the result of the decrease of HDL-C content contributing to lipid deposition in the inner wall of the vessel, leading to the occurrence of CHD ([@b17-etm-0-0-7111],[@b18-etm-0-0-7111]). The difference was not statistically significant in the HDL-C level in patients among angina pectoris, acute myocardial infarction and old myocardial infarction group (P\>0.05), but the differences were statistically significant in the levels of Hcy, TC, TG and LDL-C in serum of patients among angina pectoris, acute myocardial infarction and old myocardial infarction group (P\<0.05). The differences were statistically significant in the levels of Hcy, TC, TG and LDL-C between acute and old myocardial infarction and angina pectoris group (P\<0.05), and the differences were statistically significant in the levels of Hcy, TC, TG and LDL-C between old and acute myocardial infarction group (P\<0.05). The study of Christensen *et al* ([@b19-etm-0-0-7111]) was consistent with our results, among which the Hcy level in patients in acute myocardial infarction group was significantly higher than that in the other two groups, suggesting that the cause of myocardial infarction in patients may be the increase of Hcy contributing to occurrence of thrombosis ([@b20-etm-0-0-7111]).

Analysis of risk factors for the disease was performed using logistic regression. The results of univariate analysis showed that CHD was associated with Hcy, hyperlipidemia, smoking, hypertension and diabetes (P\<0.05), but had no relationship with drinking and obesity (P\>0.05). The results of multivariate analysis showed that Hcy, hyperlipidemia, hypertension and diabetes were independent risk factors for CHD, and the difference was statistically significant (P\<0.05). Our results are very similar to that of Menezes *et al* ([@b21-etm-0-0-7111]). According to statistics, smoking is associated with the death of CHD and is a significant risk factor for early onset of CHD, and especially the younger the smoker is, the greater the risk is ([@b22-etm-0-0-7111]). This is because long-term smoking speeds up the oxidation of LDL-C, resulting in decreased antioxidant capacity and dysfunction of blood vessel endothelium ([@b23-etm-0-0-7111]). Studies have shown that the incidence of CHD in hypertensive patients with high diastolic blood pressure is 5 times higher than that in patients with low diastolic blood pressure. About 70% of patients with type II diabetes die of CHD, the most important risk factor is dyslipidemia. In addition to some uncontrollable risk factors such as sex, age and genetic factors, people should actively control and cooperate to improve these variable risk factors ([@b24-etm-0-0-7111],[@b25-etm-0-0-7111]).

In conclusion, the Hcy level increases and the HDL-C level decreases in serum of CHD patients. Hcy, hyperlipidemia, hypertension and diabetes are independent risk factors for CHD, which can provide reference for the assessment of the disease and for the early prevention and treatment.
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![Comparison of Hcy and blood lipid levels in serum between the study and control group. (A) The results of enzyme-linked immunosorbent assay showed that the Hcy level in patients in the study group was significantly higher than that in control group (^&^P\<0.001). (B) TC was determined using enzyme method, TG using glycerol phosphate oxidase method and HDL-C and LDL-C using selective inhibition method. The results showed that the levels of Hcy, TC, TG and LDL-C in patients in the study group were significantly higher than that in control group, while the HDL-C level was significantly lower than that in control group (\*P\<0.001). Hcy, homocysteine; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.](etm-17-03-1756-g00){#f1-etm-0-0-7111}

![Comparison of Hcy and blood lipid levels in serum in different types of CHD. (A) The results of enzyme-linked immunosorbent assay showed that there was a significant difference in the Hcy level in patients among angina pectoris, acute myocardial infarction and old myocardial infarction group (\*P\<0.05). (B) TC was determined using enzyme method, TG using glycerol phosphate oxidase method and HDL-C and LDL-C using selective inhibition method. The results showed that there was no significant difference in the HDL-C level in patients among angina pectoris, acute myocardial infarction and old myocardial infarction group (P\>0.05). There was a significant difference in the levels of Hcy, TC, TG and LDL-C in patients among the three groups (P\<0.05); the differences were statistically significant in the levels of Hcy, TC, TG and LDL-C between acute and old myocardial infarction and angina pectoris group (P\<0.05); the differences were statistically significant in the levels of Hcy, TC, TG and LDL-C between old and acute myocardial infarction group (\*P\<0.05). Hcy, homocysteine; CHD, coronary heart disease; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.](etm-17-03-1756-g01){#f2-etm-0-0-7111}

###### 

General information \[n (%)\].

  Factors              Study group (n=148)   Control group (n=120)   χ^2^     P-value
  -------------------- --------------------- ----------------------- -------- ---------
  Age (years)                                                                 
    ≥54                102 (68.92)             72 (60.00)            2.315    0.128
    \<54                 46 (31.08)            48 (40.00)                     
  Sex                                                                         
    Male                 89 (60.14)            64 (53.33)            1.252    0.263
    Female               59 (39.86)            56 (46.67)                     
  Long-term smoking                                                           
    Yes                  91 (61.49)            32 (26.67)            32.360   \<0.001
    No                   57 (38.51)            88 (73.33)                     
  Long-term drinking                                                          
    Yes                  35 (23.65)            49 (40.83)            9.094    0.003
    No                 113 (76.35)             71 (59.17)                     
  Hypertension                                                                
    Yes                  87 (58.78)            23 (19.17)            42.980   \<0.001
    No                   61 (41.22)            97 (80.83)                     
  Diabetes                                                                    
    Yes                  43 (29.05)            18 (15.00)            7.445    0.006
    No                 105 (70.95)           102 (85.00)                      
  Hyperlipidemia                                                              
    Yes                  59 (39.86)            27 (22.50)            9.170    0.003
    No                   89 (60.14)            93 (77.50)                     
  BMI                                                                         
    \<18.5               39 (26.35)            23 (19.17)            9.197    0.010
    18.50--24.9          47 (31.76)            60 (50.00)                     
    \>25.0               62 (41.89)            37 (30.83)                     

###### 

Comparison of Hcy and blood lipid levels in serum between the study and control group.

  Groups          n     Hcy (µmol/l)   TC (mmol/l)   TG (mmol/l)   HDL-C (mmol/l)   LDL-C (mmol/l)
  --------------- ----- -------------- ------------- ------------- ---------------- ----------------
  Study group     148   21.06±5.28     4.64±1.06     1.96±0.33     0.85±0.13        2.29±0.57
  Control group   120   12.03±3.95     4.21±0.62     1.18±0.27     1.41±0.26        2.01±0.50
  t                     15.540         3.931         20.840        22.910           4.223
  P-value               \<0.001        \<0.001       \<0.001       \<0.001          \<0.001

Hcy, homocysteine; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.

###### 

Comparison of Hcy and blood lipid levels in serum in different types of CHD.

  Diseases                      n    Hcy (µmol/l)                                                                                            TC (mmol/l)                                                                                            TG (mmol/l)                                                                                            HDL-C (mmol/l)   LDL-C (mmol/l)
  ----------------------------- ---- ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------ ---------------- ------------------------------------------------------------------------------------------------------
  Angina pectoris               67   16.42±4.16                                                                                              5.97±1.02                                                                                              2.24±0.65                                                                                              1.18±0.42        2.59±0.47
  Acute myocardial infarction   49   23.81±5.37^[b](#tfn3-etm-0-0-7111){ref-type="table-fn"}^                                                5.72±0.95^[b](#tfn3-etm-0-0-7111){ref-type="table-fn"}^                                                1.89±0.58^[b](#tfn3-etm-0-0-7111){ref-type="table-fn"}^                                                1.03±0.21        2.42±0.46^[b](#tfn3-etm-0-0-7111){ref-type="table-fn"}^
  Old myocardial infarction     32   17.13±5.64^[a](#tfn2-etm-0-0-7111){ref-type="table-fn"},[b](#tfn3-etm-0-0-7111){ref-type="table-fn"}^   5.26±1.21^[a](#tfn2-etm-0-0-7111){ref-type="table-fn"},[b](#tfn3-etm-0-0-7111){ref-type="table-fn"}^   1.77±0.47^[a](#tfn2-etm-0-0-7111){ref-type="table-fn"},[b](#tfn3-etm-0-0-7111){ref-type="table-fn"}^   1.13±0.41        2.33±0.52^[a](#tfn2-etm-0-0-7111){ref-type="table-fn"},[b](#tfn3-etm-0-0-7111){ref-type="table-fn"}^
  F-value                            34.910                                                                                                  5.036                                                                                                  8.649                                                                                                  2.451            3.735
  P-value                            \<0.001                                                                                                 0.008                                                                                                  \<0.001                                                                                                0.090            0.026

P\<0.05, compared to acute myocardial infarction group

P\<0.05, compared to angina pectoris group. Hcy, homocysteine; CHD, coronary heart disease; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.

###### 

Univariate analysis of risk factors for CHD.

                   OR      95% CI         P-value
  ---------------- ------- -------------- ---------
  Smoking          1.463   1.064--2.013   0.031
  Drinking         1.389   1.042--1.852   0.076
  Hypertension     0.871   0.672--1.130   0.035
  Diabetes         0.457   0.261--0.801   0.029
  Obesity          0.192   0.056--0.661   0.054
  Hyperlipidemia   0.893   0.772--1.108   0.027
  Hcy              1.814   0.925--3.558   0.002

CHD, coronary heart disease; Hcy, homocysteine.

###### 

Multivariate analysis of risk factors for CHD.

                   OR      95% CI         P-value
  ---------------- ------- -------------- ---------
  Smoking          1.356   1.064--2.013   0.064
  Hypertension     0.843   0.776--1.130   0.028
  Diabetes         0.352   0.261--0.504   0.031
  Hyperlipidemia   0.759   0.634--1.034   0.023
  Hcy              1.736   0.925--3.687   0.022

CHD, coronary heart disease; Hcy, homocysteine.
